Table 3.
Biomarker Discovery in Diabetic Retinopathy
| Prediction | Detective Method | Metabolic Biomarkers | Ref. |
|---|---|---|---|
| Proliferative diabetic retinopathy (PDR) | LC-MS | Pyruvate, lactate, proline, allantoin, creatine | [83] |
| DR | LC-MS | Total DMA, tryptophan, and kynurenine | [84] |
| PDR | LC-MS | Inosine, hypoxanthine, urate, allantoate | [85] |
| DR | GC‐MSM, LC‐MSM, and LC‐MSL | 2-piperidone and 12-hydroxyeicosatetraenoic acid (12-HETE) | [86] |
| PDR | LC-MS | Fumaric acid, uridine, acetic acid, and cytidine | [87] |
| DR | LC-MS | Arginine, citrulline, glutamic γ-semialdehyde, and dehydroxycarnitine | [88] |
| PDR | LC-MS | Arginine and Carnitine | [88] |
| DR | 1 H-NMR | Lactate, succinate, 2-hydroxybutyrate, asparagine, dimethylamine, histidine, threonine, and glutamine | [89] |
| DR | GC-MS | Threonic acid, d-2,3-Dihydroxypropanoic acid, l-Lactic acid, isocitric acid, fructose 6-phosphate, l-threonine, ornithine, l-glutamine, pyroglutamic acid, pyruvic acid, and l-alanine | [90] |
| DR | GC-MS, LC-MS | Plasma glutamine, glutamic acid, and their ratio | [91] |
| DR | LC-MS | FAS, LPCs, LPC-Os, LPEs, LPE-ps, Cers, CerG1s, etc | [92] |